Merion Technologies (MIR) Q4 2025: Nuclear Power Orders Surge 52% as Backlog Hits Record High
Merion Technologies’ nuclear power momentum accelerated in Q4 2025, as record order growth and strategic acquisitions pushed backlog and market exposure to new highs. Execution on procurement and operational leverage drove margin expansion despite select end-market softness, while the company’s integration of Paragon and Certrek is reshaping its nuclear power and SMR opportunity set. With a robust pipeline and margin tailwinds, management is signaling confidence in double-digit organic growth and further cash flow gains for 2026.
Summary
- Nuclear Power Expansion: Acquisitions and organic growth have repositioned Merion with 40% nuclear power exposure and a record backlog.
- Margin Upside from Integration: Early synergy wins and procurement savings are driving EBITDA margin expansion despite recent margin dilution from Paragon.
- SMR and AI Initiatives: Strategic bets in SMRs and AI-enabled productivity are set to shape future competitive advantage and margin trajectory.
Business Overview
Merion Technologies is a global provider of radiation detection, measurement, and monitoring solutions for nuclear power, nuclear medicine, defense, research, and industrial markets. The business operates in two main segments: Nuclear & Safety (covering power generation, installed base, SMRs, defense, and labs) and Medical (nuclear medicine, dosimetry, and RTQA, or radiation therapy quality assurance). Revenue is generated from hardware, software, services, and regulatory compliance solutions across the full nuclear lifecycle.
Performance Analysis
Q4 capped a year of record order intake, with total orders up 26% and nuclear power orders up 52% year-over-year, reflecting both robust end-market demand and the impact of large project wins. The backlog increased 36% versus last year, now fueled by Paragon and Certrek acquisitions, which together pushed nuclear power to 40% of company revenue. Organic revenue growth was led by nuclear power (11%) and nuclear medicine (13%), though overall top-line results fell short of initial guidance due to softness in RTQA and labs and research.
Margin expansion was a highlight, with adjusted EBITDA up 12% and margins expanding 90 basis points for the full year, driven by procurement initiatives and operating leverage. Free cash flow more than doubled, aided by lower interest expense from debt refinancing and improved working capital discipline. Medical segment revenue was flat, constrained by tough comps and hardware headwinds in RTQA, but delivered strong margin expansion through OPEX initiatives and procurement savings.
- Backlog Acceleration: Paragon and Certrek contributed to a record backlog, positioning Merion for sustained growth into 2026 and beyond.
- Segment Divergence: Nuclear power and nuclear medicine outperformed, while labs and RTQA faced demand deferral, not secular decline.
- Cash Flow Leverage: Free cash flow conversion reached 57%, with capital structure improvements lowering cost of debt to 2.9%.
Management expects these dynamics—especially in nuclear power and medical margin expansion—to underpin double-digit organic growth and higher free cash flow in 2026, with further margin upside as integration and AI initiatives scale.
Executive Commentary
"We booked record orders in 2025, totaling more than $1 billion. This was largely driven by the nuclear power market strength we've been highlighting throughout the year... Both [Paragon and Certrek] acquisitions augment our North American nuclear power exposure and take our nuclear power revenue to roughly 40% of the total."
Tom Logan, Founder, Chairman and CEO
"Fourth quarter enterprise revenue grew 9%... Over half of the year-over-year improvement came from M&A. Adjusted EBITDA margins expanded 60 basis points despite margin dilutive impacts from Paragon... Q4 orders increased 62%, reflecting 140 million of large opportunity orders awarded in Q4 from the nuclear power end market."
Brian Shopper, CFO and Medical Group President
Strategic Positioning
1. Nuclear Power Scale and Installed Base Leverage
With nuclear power now at 40% of revenue and 80% of that tied to the installed base, Merion has built a durable, recurring revenue engine less dependent on new build cycles. Life extensions, plant modernization, and up-rate projects are driving demand visibility, while the company’s presence in nearly every operating nuclear plant globally anchors its competitive moat.
2. SMR (Small Modular Reactor) Pipeline and Customer Intimacy
Strategic moves into SMRs—through Paragon, Certrek, and direct engagement with 20+ developers—are expanding Merion’s top-of-funnel opportunity set. While still a small share of total revenue (sub-3% for 2026), SMR orders more than doubled in 2025, and management sees these early wins as catalysts for broader innovation and future wallet share gains.
3. Procurement, Synergy, and AI-Driven Productivity
Procurement initiatives delivered nearly 100 basis points of margin expansion in 2025, and further self-help is expected as Paragon and Certrek are integrated. The company launched 17 internal AI applications to boost productivity, with a newly hired Chief AI and Digital Officer tasked to accelerate both customer-facing and internal efficiency gains. Management sees AI as a meaningful lever for both margin and top-line growth.
4. Medical Segment Margin Focus Amid Top-Line Headwinds
Despite flat revenue, the medical segment delivered 260 basis points of margin expansion for the year, with OPEX and procurement initiatives offsetting hardware softness. Leadership is prioritizing software and services growth, as well as strategic partnerships, to drive higher-value recurring revenue in nuclear medicine and RTQA.
5. Capital Structure Optimization and Cash Flow Discipline
Debt refinancing and convertible note issuance reduced Merion’s cost of debt from 7.4% to 2.9%, freeing up capital for strategic investments in AI and integration. Free cash flow doubled, and management expects continued improvement in 2026, supporting both organic and inorganic growth ambitions.
Key Considerations
Merion’s 2025 results highlight a business in transition—scaling its nuclear power franchise, absorbing recent acquisitions, and investing in future productivity levers. The following factors will shape the company’s trajectory in 2026 and beyond:
Key Considerations:
- Order Book Quality: Large project wins and a growing pipeline underpin backlog strength, but timing and ramp pace of these projects are inherently lumpy.
- Integration Execution: Rapid Paragon and Certrek integration is critical for realizing identified synergies and margin accretion within the planning horizon.
- AI and Digital Leverage: Success in scaling proprietary AI tools and digital offerings could unlock further efficiency and commercial differentiation.
- End-Market Normalization: RTQA and labs/research softness is expected to abate, but recovery pace will be key for segment balance.
- Capital Allocation Discipline: Continued cash flow improvement and prudent debt management support flexibility for future M&A or strategic initiatives.
Risks
Key risks include project timing volatility, especially for large nuclear and SMR contracts, and the margin dilutive impact of recent acquisitions until synergies are fully realized. End-market cyclicality—particularly in labs, research, and hardware-heavy medical segments—could persist if macro or government funding headwinds linger. Tariff exposure and regulatory shifts remain ongoing watchpoints, while the ambitious AI and integration roadmap carries execution risk if productivity or commercial gains do not materialize as planned.
Forward Outlook
For Q1 2026, Merion guided to:
- Low single-digit organic revenue growth (company-wide), with medical mid-single digit and nuclear and safety flat
- EBITDA margin contraction in Q1 due to Paragon dilution and tough comps in the sensing business
For full-year 2026, management provided:
- 22% to 24% total revenue growth (5% to 7% organic)
- Adjusted EBITDA of $285 to $300 million (margin expansion of ~90 basis points)
- Adjusted free cash flow of $155 to $175 million
- Adjusted EPS of $0.50 to $0.57 (now including stock-based comp)
Management emphasized tailwinds from backlog, Paragon and Certrek integration, and margin improvement initiatives, while cautioning that Q1 will be seasonally light and margin-dilutive, with expansion returning in the back half.
- Large order ramp is expected to accelerate after initial light contribution in year one
- Medical segment set for margin expansion and mid-single digit growth as hardware headwinds moderate
Takeaways
Merion is executing a strategic pivot toward nuclear power scale, with acquisitions and backlog strength supporting a multi-year growth runway.
- Backlog and Order Momentum: Record nuclear power orders and a 36% increase in backlog set up strong visibility for 2026, with SMR and installed base projects as key growth levers.
- Margin and Cash Flow Leverage: Procurement and synergy capture are driving margin expansion even as integration of Paragon and Certrek temporarily dilutes near-term margins.
- Future Watchpoints: Investors should monitor the pace of large project conversion, SMR commercialization, and the realized impact of AI and digital initiatives on both efficiency and customer traction.
Conclusion
Merion Technologies exits 2025 with strengthened nuclear power positioning, a record backlog, and clear visibility into double-digit organic growth for 2026. The company’s ability to integrate recent acquisitions, execute on margin expansion, and scale digital and AI initiatives will determine whether it can sustain its current momentum and deliver on its path to 30%+ EBITDA margins by 2028.
Industry Read-Through
Merion’s results reinforce nuclear power’s resurgence as a critical enabler for grid stability and data center expansion, with the installed base, life extensions, and SMR development driving multi-year demand visibility. Peers in nuclear equipment, instrumentation, and compliance are likely to see similar backlog and order momentum, especially if they can replicate Merion’s installed base leverage and customer intimacy strategies. AI-driven productivity and data monetization are emerging as differentiators for industrial tech providers, and the sector’s winners will be those who can both digitize their core and capitalize on the accelerating energy transition tailwinds.